PMVPPMV PharmaceuticalsPMVP info
$1.51info0.67%24h
Global rank22703
Market cap$77.25M
Change 7d-1.31%
YTD Performance-51.29%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    PMV Pharmaceuticals (PMVP) Stock Overview

    PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations, including R273H, R273C, R175H, G245S, R248Q, and R282W, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

    PMVP Stock Information

    Symbol
    PMVP
    Address
    8 Clarke DriveCranbury, NJ 08512United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.pmvpharma.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    609 642 6670

    PMV Pharmaceuticals (PMVP) Price Chart

    -
    Value:-

    PMV Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.51
    N/A
    Market Cap
    $77.25M
    N/A
    Shares Outstanding
    51.16M
    N/A
    Employees
    62.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org